Sotagliflozin (Inpefa) structure · SGLT2 inhibitor

Sotagliflozin (Inpefa) 2D structure

Role: Drug
Family: SGLT2 inhibitor series
Mechanism class: SGLT2 inhibitor
Parent scaffold: C-glucoside SGLT2 pharmacophore

Structure source: Catalog seed

How similarity is calculated

Hand-written analysis

Mechanism

소타글리플로진은 SGLT1/2 이중 저해제입니다. 장 SGLT1 차단이 식후 당·인크레틴에 추가로 영향을 줍니다. 심부전 맥락 데이터가 있습니다.

Medicinal chemistry

C-글루코사이드이되 SGLT1 잔여가 다른 SGLT2 선택약보다 큽니다.

Indication · context

당뇨·심부전 라벨을 확인하십시오. 선택적 SGLT2와 한 문장으로 합치지 않습니다.

SMILES

CCOC1=CC=C(C=C1)CC2=CC(=CC(=C2)C3=CC=C(C=C3)Cl)C4=CC(=CC(=C4)C5=CC=CC=C5)OCC6C(C(C(C(O6)CO)O)O)OCC7=CC=C(C=C7)F

Related compounds

External IDs · BioMoa

PubChem 검색 ChEMBL 검색 PubChem (SMILES)BioMoa · BioMoa에서 검색 BioMoa · SGLT2 inhibitor BioMoa bridge Open on the family map Flow Structure table Mechanism class

StructureMoa is a chemical-structure exploration tool. Structural similarity, clustering, and SAR relationships are intended for research exploration and do not establish shared potency, selectivity, safety, efficacy, or clinical performance.

Methodology

Sotagliflozin (Inpefa) structure · mechanism